Director Dealing

RNS Number : 6506S

Physiomics PLC

22 December 2016

 

Physiomics plc

("Physiomics" or the "Company")

Director Dealing

The Company announces that it received notice today that Dr Jim Millen, the Company's CEO, has purchased a total of 200,000 ordinary shares in the Company at a price of 2.5p per share, being the most recent placing price, as announced on 21 September 2016, adjusted for the subsequent share consolidation. Following this transaction Dr Millen owns 200,000 ordinary shares in the Company representing approximately 0.35 per cent of the issued share capital of the Company.

Enquiries:

Physiomics plc

Dr Jim Millen, CEO

[phone]

WH Ireland Limited (nomad)

Katy Mitchell

[phone]

Hybridan LLP (broker)

Claire Louise Noyce

[phone]

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Dr Jim Millen
2	Reason for the notification
a)	Position/status	CEO
b)	Initial notification/ Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Physiomics plc
b)	LEI	N/A
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of 0.004p GB00BDR6W943
b)	Nature of the transaction	Purchase of shares
c)	Price(s) and volume(s)	Price(s) Volume(s) 2.5p 200,000
d)	Aggregated information -     Aggregated volume -     Price	200,000 2.5p
e)	Date of the transaction	22 December 2016
f)	Place of the transaction	London Stock Exchange, AIM

 

END

 

 

DSHTTBATMBTTBLF